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Improving performance of substance use disorder treatment systems is no easy matter 
and one prone to unintended consequences. All the more welcome then is guidance from 
leading US experts with top-level experience in the UK and the USA; their favourite 
tactic, rewarding services for patient progress during treatment, is featured in UK 
payment-by-results schemes.
Summary Two US experts who worked at top levels on drug policy for the current US 
president and have advised the UK government draw on scientific literature and their 
experiences to offer policy makers an overview of system-level strategies to improve the 
outcomes of services for substance use disorder patients. Their aim was to stimulate 
discussion rather than conduct a systematic and comprehensive review of the evidence.
Though they may be used together, the review divides the strategies in to process-
focused quality improvement strategies which change how treatment staff work in the 
expectation that this will improve patient outcomes, and patient-focused strategies which 
concentrate on outcomes without specifying how those are to be achieved.
Process-focused quality improvement strategies
Substantial deficits in the quality of substance use disorder care in the USA and the UK 
include an excess of paperwork, insufficient time with patients, demoralised staff, lack of 
medically trained staff, dysfunctional organisational dynamics, and underuse of scientific 
evidence. Strategies under this heading seek to change organisational, financial and 
clinical practices to redress such deficits. These improvements will it is hoped translate 
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into better patient outcomes, but this cannot be assumed. In general, the longer the time 
between receipt of services and outcome measurement, the less the outcome can be 
taken as indicative of the quality of those services.
Increasing licensure/credentialing requirements
Most US addiction treatment programmes have no physicians or nurses and the primary 
credential of many counsellors (to an extent also in the UK) is themselves being in 
recovery. It therefore seems logical that increasing credentialing requirements for staff 
will improve quality.
However, such stiffening would exacerbate staff recruitment and retention problems 
unless accompanied by inducements to make a career in the field more attractive. Also, 
credentialing has become an entrepreneurial activity; countless organisations develop 
and sell credentials which do not always assure quality. Finally, the evidence from 
hundreds of clinical trials is that counselling outcomes are not predicted at all by the 
counsellor's type or level of educational degree; a prestigious degree in medicine, for 
example, does not ensure that a physician can make an emotional connection to an 
addicted homeless patient or an alcoholic soldier suffering post-traumatic stress disorder.
Despite these caveats, legitimate credentialing and licensure could help weed out 
unsuitable individuals, some credentials are essential to clinical activities such as 
prescribing medication or taking blood, and more highly educated staff are particularly 
receptive to evidence-based practices.
Beyond these rather gross indicators of value, new credentialing policies are a weak lever 
for improving addiction service outcomes, though one which might be stronger if focused 
on specific clinical competencies rather than coursework or hours of training.
Measuring and/or incentivising evidence-based clinical practices
Evidence-based clinical practices which have been incentivised in the USA include 
screening primary care patients for drinking problems and retaining patients in specialist 
treatment for at least three months. US health-care systems have also begun to monitor 
the proportion of patients whose substance use disorder is identified, the proportion who 
engage early in care, and the proportion retained in care over time.
Such incentives can lead to dramatic improvements in hitting these targets. However, 
achieving them can bear at best a weak relationship to subsequent patient outcomes, 
shown among others by US studies of targets like the three-month retention measure 
also adopted in the UK. Research has shown that treatment providers respond to 
incentives (important in itself), but has yet to clarify which provider practices should be 
changed to improve patient outcomes.
Another issue is whether anyone other than the providers themselves should be made 
aware of how closely they follow evidence-based guidelines. A recent trial found that 
giving treatment services feedback on their patients' progress had no effect on clinical 
performance, confirming that if there are no consequences from doing so, information on 
one's performance is generally disregarded. Performance assessments are best made 
public if the goal is to improve outcomes.
Improving managerial capacity and business practices
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This strategy involves expert business consultants helping treatment services improve 
their management skills, knowledge and capacity. The highest-profile US efforts are the 
Network for the Improvement of Addiction Treatment (NIATx) and the follow-on 
Advancing Recovery project.
An intriguing strategy employed by NIATx is the 'walkthrough'. Managers attempt to 
access care in their own services from the patient's point of view – for many, an eye-
opening experience which helped explain low rates of treatment entry and retention. 
Other management practices taught in these initiatives include careful analysis and 
allocation of funding and better development of a business case for new funding. In 
response, services reduced waiting times and increased retention, and these gains 
persisted after intensive organisational consultation had ended.
The Advancing Recovery project generally improved continuity of care and use of 
evidence-based pharmacotherapies. However, both initiatives probably attracted better-
organised and led and more motivated services; effects are likely be less dramatic if such 
initiatives are applied to all services. Also, as yet changes in care processes have not 
been related to long-term patient outcomes.
Embedding substance use disorder care in a higher quality care network
An example of this strategy is the Obama administration's policy of medicalising care for 
substance use disorders. Through funding for screening and brief intervention in primary 
care settings and changes in public and private insurance, it has begun transplanting 
substance use care into general health care. This brings with it features which may 
improve patient outcomes, such as medically trained staff, availability of medications, 
financial incentives for quality, electronic health record monitoring of patients, and a 
broad culture of careful inspections and monitoring. Co-location should also facilitate 
access to supplemental medical services. Finally, integrated care coordinated by one's 
usual GP may be more accessible and less stigmatising than going to an 'addiction 
treatment programme', meaning it may also be possible to engage lower severity and 
more manageable patients.
However, this does not guarantee quality improvement. Medical care systems could re-
allocate resources intended for substance use disorder care, and patients may be treated 
by less knowledgeable practitioners. Integration remains a promising idea in search of 
rigorous evidence rather than something which can be assumed to work.
Patient-focused strategies
Another class of strategies focus on the patient's actual outcomes rather than 
organisational or clinical practices. From this perspective, some of quality improvement 
strategies described above may be criticised for not focusing on what ultimately matters 
most, a point strengthened by research showing how changing care processes has often 
not translated into better patient outcomes and can have negative side effects. The 
patient-focused approaches described under this heading have been implemented less 
frequently in the addictions than process-focused strategies, so examples are drawn from 
treatment of other disorders.
Rewarding post-treatment outcomes
In some health care sectors providers are directly incentivised to produce specific long-
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term patient outcomes. An example from substance use treatment is the payment-by-
results programme launched by the UK government, the first in this sector.
One issue is that what happens to a chronically ill individual after treatment becomes less 
closely linked to care quality over time. Measuring outcomes too long after treatment 
could demoralise providers held accountable for things over which they have little 
control. Another risk is that providers will exclude patients with a poor prognosis. Also, 
the cost of re-assessing patients after treatment can be considerable. When this task is 
assigned to clinicians, follow-up rates and data are poor and time is diverted from 
treating patients. It is better to use an independent outcomes monitoring team, but this 
requires a continuing resource commitment.
Rewarding in-treatment performance
Another approach is to reward services for outcomes attained during treatment. This 
resolves several problems with the previous strategy: finding the patient is easier, and 
what the provider does should bear a stronger relation to how the patient is doing. Of the 
outcome improvement approaches described in this paper, this is among the most 
promising and feasible, not only because it could improve care, but because it focuses 
clinicians' attention on something they can and should be responsible for throughout the 
care process.
One such experiment in the US state of Maine initially generated enthusiasm. Services 
were funded for raising the proportion of patients who by their final contact with the 
service had achieved outcomes such as abstinence or major reduction in substance use. 
Performance appeared to improve, but this seemed due to services treating fewer 
severely troubled clients. Patients may also have been less candid when their accounts of 
their substance use affected their clinician's income. The system was updated but the 
most recent evaluation again yielded disappointing results.
It is not necessarily that this approach cannot work, but that performance contracts need 
to reward objective outcomes such as urine test results and adjust these rewards in the 
light of the service's case-mix. Such a system has been trialled in US methadone clinics 
which were informed of their performance, but with no financial or reputational 
consequences attached, there is no evidence that this changed clinical practice or 
improved patient outcomes.
Some clinicians might say such approaches are not feasible because they require regular 
monitoring of patients' substance use. However, this should happen anyway as good 
clinical practice. Research is, however, still needed to establish the strength of the 
relationship between in-treatment progress and longer term, post-treatment outcomes.
Rewarding patients for attaining particular outcomes
Individuals with substance use disorders do respond to incentives and sanctions such as 
short jail terms or housing linked to positive drug/alcohol tests, or those given by 
contingency management treatment programmes which systematically levy material 
rewards or privileges for abstinence or other outcomes.
Paying patients can however be resisted by the public and sometimes care providers too 
on the basis for example that 'They ought to change for free like everyone else'. Non-
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financial rewards and stressing the public benefits of these schemes (such as safer 
neighbourhoods) can help. Changes induced by external rewards sometimes reverse once 
rewards end. Such schemes may however be useful in the early stages of treatment to 
promote progress and engagement with care.
Making the patient a customer with purchasing power
A radically different approach tried in the USA gave individuals early in the recovery 
process vouchers to buy whatever services they thought would aid their recovery. 
Examples included college classes, transport to work or to self-help group meetings, 
housing, dental care, work training and clothes for job interviews. In theory this should 
generate improvements via the mechanisms that drive efficiency and quality in 
commercial markets. Access to Recovery, as the programme is called, expanded both the 
number of organisations providing services and the number of recipients. More 
importantly, outpatients in Washington state who received vouchers stayed longer in 
treatment and were more likely to be employed than comparison patients.
'Personal health budgets' being piloted for health and social care in the NHS are 
analogous. In consultation with a health professional, chronically ill individuals are given 
a fixed pool of funds from which they can buy a range of services, assembling a care 
package tailored to their needs. Extension to the addictions has been discussed within 
government, but it is not clear whether this will be tried.
The authors' conclusions
Strategies policy makers can use to improve outcomes of substance use disorder 
treatment are often poorly developed with weak empirical support. Incentives for 
particular clinical practices can change what systems do, but it is less clear which 
changes translate into better patient outcomes; some such schemes have proved literally 
worse than doing nothing. Cases discussed in this paper in which care utilisation was 
incentivised, but outcomes did not improve, mean money was spent on care that was 
apparently not needed, which may have adversely affected other patients due to the 
diversion of resources.
Despite a small evidence base, bringing market forces targeting quality and effectiveness 
to bear on treatment systems – including directly rewarding outcomes – has significant 
practical and logical appeal. Particularly promising are initiatives focused on in-treatment 
performance rather than long-term post-treatment outcomes. Also promising are 
vouchers that give patients purchasing power for their chosen services, hopefully to be 
extended to substance use disorders, perhaps via the British health service's personal 
health budgets.
When implementing such programmes policy makers serve themselves and the field if 
they embed careful, realistic evaluations from the start. The required investment and 
level of collaboration are substantial, but justified by the potential payoff in knowledge 
about how to enhance care for life-threatening disorders.
 This advice from two of the world's most respected addiction researchers, 
each also with top-level experience in government drug policy, usefully and lucidly sets 
out the options for making improvements to treatment systems. Exactly what those 
improvements are intended to achieve was left open, so its findings should apply to the 
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ambitions of recovery-focused UK national strategies.
Realistically they observe that quality improvement initiatives often seem to bear little 
relationship to what really improves outcomes for the patient and society, because 
outcomes do not in fact improve at all or very much. Treatment is a relationship 
business; mechanistic pulling of levers may shift the gears but not touch the heart of the 
matter, resulting in surface changes which do not last, a common experience in 
contingency management programmes which reward and sanction patients for desired 
behaviour or non-behaviour.
As the authors explain, in turn this means that credentials and training courses 
completed may mean little when it comes to forging engagement- and outcome-
enhancing relationships. Studies can, for example, isolate personality variables which 
when high or low mean that on average patients respond best to certain types of 
counselling styles. However, the complexity of each individual means that what is 
indicated for one aspect of their situation or character may be counter-indicated by 
another, leaving the sensitivity of the therapist to sort out the best approach. Tying their 
hands too tightly through detailed treatment manuals (no matter how expert the author) 
and supervision to ensure they stick to the script has in the case of motivational 
interviewing led to worse outcomes, not better.
One implication the reviewers do not touch on is that without appropriate recruitment, 
much of the quality improvement effort put in to training and supervision will be wasted. 
This was the message which emerged from a study of motivational interviewing training 
which found that initial gains in skills had waned two months later. However, this was not 
the case for the addiction and mental health clinicians who, even before training, had 
been more proficient than the other trainees would be after training. Not only did these 
'natural experts' start from a higher level, they went on to absorb and retain more of 
what they had learned.
UK payment by results schemes
Though featured under schemes which reward post-treatment outcomes, nationally 
agreed outcomes for pilot payment by results schemes in England often specify in-
treatment and treatment exit measures, placing them partly within the during-treatment 
payment schemes favoured by the featured review. One of the problems it identifies with 
post-treatment payment schemes – the resources needed to re-contact and reassess 
patients – is sidestepped by using routinely collected criminal justice and treatment 
records which do not require contact with the patient. Reports from the pilots suggest 
these schemes can both be feasible and generate innovations focused sharply on 
achieving results.
The British schemes attempt to balance in-treatment and treatment exit measures 
against longer term crime and relapse indicators, generally choosing to place greater 
financial weight on the longer term. This means services must wait many months – in 
respect of some measures nearly two years – to receive much of their funding under the 
scheme, a cash-flow problem which requires counter-measures if services are to survive. 
Arguably too, as the featured reviewers comment, services are placed at financial risk for 
outcomes over which they may have little control because they are so far from the time 
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when they had direct influence over the patient.
The alternative of weighting in favour of during treatment and treatment end measures 
falls foul of the observation in the featured report that these are often loosely related to 
the longer term recovery the system is trying to generate. For example, 'successfully' 
completing treatment free of dependence and of opiate and crack cocaine use did mean 
that over the next four years more patients in England appeared to have avoided relapse, 
but the difference of 57% versus 43% who did not successfully complete was not as 
large as would be expected if successful completion correlated strongly with lasting 
recovery.
Such schemes are classed by the reviewers as "patient-focused strategies" – not to be 
confused with patient-centred practice in the sense of basing treatment objectives and 
methods on the patient's preferences and priorities. Being patient-focused in this sense is 
threatened by payment by results schemes because these pre-set the treatment 
destination in detail without reference to what the individual patient wants, and in a way 
services cannot afford to ignore because their financial survival depends on meeting the 
criteria for payment. Local schemes could still create a space for the patient's ambitions 
in their payment criteria, but this is not a required element or one included in the 
national outcomes schema, nor one which sits easily within a system predicated on 
observable outcomes the public and their representatives recognise and are willing to pay 
for.
As a commentator on the featured review pointed out, schemes which make payment 
contingent on either process or outcomes entail a regulatory overhead which could eat in 
to whatever efficiencies are achieved at the services concerned. For example, the 
reviewers rightly caution that "performance contracts need to reward outcomes that are 
objective (eg, urine testing) and case-mix-adjusted". This means some authority has to 
assess the severity of the caseload in terms of the resources needed to achieve the 
intended outcomes, and assess whether those outcomes have been achieved in ways 
which go beyond merely asking the patient. When funding, jobs and organisational 
survival ride on these assessments, leaving them entirely to the people and organisations 
at threat may stretch their integrity too far. This concern spawns new regulatory 
requirements and possibly new regulatory bodies which must, as the Audit Commission 
described, be capable of overcoming complexity to deliver valid and meaningful 
measures if disputes, demoralisation and wastage are to be avoided.
In UK payment by results schemes the most visible result has been the setting up of 
central assessment centres (or LASARS), which have a key role in setting tariffs based on 
patient severity and verifying outcomes. These say the Gaming Commission should be 
independent both of treatment services and the commissioners of those services to make 
them less vulnerable to pressure to manipulate the figures (or at least the suspicion that 
this is happening), meaning a new body with its own overheads, which itself may require 
regulation. An independent assessment centre also places another step in the journey to 
accessing treatment during which access may falter. The plus side may be more efficient 
assessment, better treatment placement, and the potential for long-term case 
management to start at the assessment stage, but these possible advantages could have 
been achieved by centralising within existing structures.
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any remaining errors. 
Last revised 20 September 2012
 Comment on this entry•  Give us your feedback on the site (one-minute survey)
Top 10 most closely related documents on this site. For more try a subject or 
free text search
Performance-based contracting within a state substance abuse treatment system: a preliminary exploration of 
differences in client access and client outcomes STUDY 2011
Therapist effectiveness: implications for accountability and patient care STUDY 2011
The Patel report: Reducing drug-related crime and rehabilitating offenders DOCUMENT 2010
Implementing evidence-based psychosocial treatment in specialty substance use disorder care REVIEW 2011
Scottish Drugs Strategy Delivery Commission: first year report & recommendations to minister DOCUMENT 2011
The forgotten carers: support for adult family members affected by a relative's drug problems STUDY 2012
Supporting partnerships to reduce alcohol harm: key findings, recommendations and case studies from the 
Alcohol Harm Reduction National Support Team STUDY 2011
Effective dissemination: a systematic review of implementation strategies for the AOD field REVIEW 2008
Drug and alcohol services in Scotland STUDY 2009
Alcohol dependence and harmful alcohol use quality standard DOCUMENT 2011
http://findings.org.uk/count/downloads/download.php?file=Humphreys_K_27.txt (8 of 8) [20/09/12 15:50:14]
